AZN logo

AstraZeneca PLC (AZN) Free cash flow

annual FCF:

$7.28B+$708.00M(+10.78%)
December 31, 2024

Summary

  • As of today (August 22, 2025), AZN annual free cash flow is $7.28 billion, with the most recent change of +$708.00 million (+10.78%) on December 31, 2024.
  • During the last 3 years, AZN annual FCF has risen by +$3.51 billion (+93.33%).
  • AZN annual FCF is now -28.35% below its all-time high of $10.15 billion, reached on December 31, 2009.

Performance

AZN Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

quarterly FCF:

$1.56B-$1.25B(-44.46%)
June 30, 2025

Summary

  • As of today (August 22, 2025), AZN quarterly free cash flow is $1.56 billion, with the most recent change of -$1.25 billion (-44.46%) on June 30, 2025.
  • Over the past year, AZN quarterly FCF has dropped by -$968.74 million (-38.29%).
  • AZN quarterly FCF is now -55.00% below its all-time high of $3.47 billion, reached on December 31, 2009.

Performance

AZN quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

TTM FCF:

$8.49B-$968.74M(-10.25%)
June 30, 2025

Summary

  • As of today (August 22, 2025), AZN TTM free cash flow is $8.49 billion, with the most recent change of -$968.74 million (-10.25%) on June 30, 2025.
  • Over the past year, AZN TTM FCF has increased by +$1.16 billion (+15.84%).
  • AZN TTM FCF is now -17.95% below its all-time high of $10.34 billion, reached on December 31, 2009.

Performance

AZN TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

AZN Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.8%-38.3%+15.8%
3 y3 years+93.3%+119.3%+58.6%
5 y5 years+1329.3%+2068.4%+409.1%

AZN Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+93.3%-44.5%+119.3%-10.3%+58.6%
5 y5-yearat high+1329.3%-45.6%+2068.4%-10.3%+409.1%
alltimeall time-28.4%+3733.8%-55.0%+163.8%-17.9%>+9999.0%

AZN Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.56B(-44.5%)
$8.49B(-10.2%)
Mar 2025
-
$2.81B(+39.6%)
$9.46B(+24.1%)
Dec 2024
$7.28B(+10.8%)
$2.01B(-4.1%)
$7.62B(+7.0%)
Sep 2024
-
$2.10B(-17.0%)
$7.12B(-2.9%)
Jun 2024
-
$2.53B(+159.8%)
$7.33B(+20.1%)
Mar 2024
-
$974.00M(-35.6%)
$6.10B(-11.0%)
Dec 2023
$6.57B(-9.3%)
$1.51B(-34.5%)
$6.85B(-5.1%)
Sep 2023
-
$2.31B(+77.3%)
$7.22B(+7.0%)
Jun 2023
-
$1.30B(-24.7%)
$6.75B(+9.6%)
Mar 2023
-
$1.73B(-7.9%)
$6.16B(-15.7%)
Dec 2022
$7.24B(+92.3%)
$1.88B(+2.3%)
$7.30B(+19.1%)
Sep 2022
-
$1.83B(+157.7%)
$6.13B(+14.5%)
Jun 2022
-
$712.00M(-75.2%)
$5.35B(+3.3%)
Mar 2022
-
$2.87B(+306.8%)
$5.18B(+36.4%)
Dec 2021
$3.76B(+71.6%)
$706.00M(-33.4%)
$3.80B(-12.6%)
Sep 2021
-
$1.06B(+95.6%)
$4.34B(-1.4%)
Jun 2021
-
$542.00M(-63.6%)
$4.41B(+11.9%)
Mar 2021
-
$1.49B(+18.7%)
$3.94B(+75.8%)
Dec 2020
$2.19B(+330.8%)
$1.25B(+11.7%)
$2.24B(+12.4%)
Sep 2020
-
$1.12B(+1459.7%)
$1.99B(+19.6%)
Jun 2020
-
$72.00M(-134.4%)
$1.67B(+8.6%)
Mar 2020
-
-$209.00M(-120.8%)
$1.53B(+142.5%)
Dec 2019
$509.00M(-59.2%)
$1.01B(+26.3%)
$633.00M(-57.3%)
Sep 2019
-
$797.00M(-1428.3%)
$1.48B(+61.9%)
Jun 2019
-
-$60.00M(-94.6%)
$916.00M(+19.0%)
Mar 2019
-
-$1.11B(-159.8%)
$770.00M(-46.5%)
Dec 2018
$1.25B(-36.3%)
$1.86B(+707.4%)
$1.44B(+1820.0%)
Sep 2018
-
$230.00M(-211.7%)
$75.00M(-95.8%)
Jun 2018
-
-$206.00M(-53.3%)
$1.78B(-8.0%)
Mar 2018
-
-$441.00M(-189.6%)
$1.93B(-8.9%)
Dec 2017
$1.96B(+6.9%)
$492.00M(-74.5%)
$2.12B(-28.9%)
Sep 2017
-
$1.93B(-3890.2%)
$2.98B(+94.0%)
Jun 2017
-
-$51.00M(-79.8%)
$1.54B(+94.7%)
Mar 2017
-
-$252.00M(-118.6%)
$790.00M(-59.9%)
Dec 2016
$1.83B(+241.6%)
$1.35B(+178.0%)
$1.97B(+192.4%)
Sep 2016
-
$487.00M(-161.0%)
$674.00M(-53.2%)
Jun 2016
-
-$799.00M(-186.0%)
$1.44B(-46.5%)
Mar 2016
-
$929.00M(+1529.8%)
$2.69B(+309.0%)
Dec 2015
$536.00M(-87.6%)
$57.00M(-95.5%)
$659.00M(-67.5%)
Sep 2015
-
$1.25B(+175.6%)
$2.03B(-13.3%)
Jun 2015
-
$455.00M(-141.1%)
$2.34B(-18.0%)
Mar 2015
-
-$1.11B(-177.7%)
$2.85B(-35.9%)
Dec 2014
$4.31B(-19.4%)
$1.43B(-8.9%)
$4.45B(-6.3%)
Sep 2014
-
$1.56B(+61.8%)
$4.75B(+22.6%)
Jun 2014
-
$967.00M(+97.8%)
$3.87B(-6.6%)
Mar 2014
-
$489.00M(-71.6%)
$4.14B(-23.7%)
Dec 2013
$5.34B(+129.4%)
$1.72B(+149.5%)
$5.43B(-10.0%)
Sep 2013
-
$691.08M(-44.2%)
$6.03B(+92.3%)
Jun 2013
-
$1.24B(-30.2%)
$3.14B(+7.9%)
Mar 2013
-
$1.77B(-23.7%)
$2.91B(+17.1%)
Dec 2012
$2.33B(-64.3%)
$2.32B(-205.5%)
$2.48B(-13.4%)
Sep 2012
-
-$2.20B(-318.2%)
$2.86B(-57.7%)
Jun 2012
-
$1.01B(-25.2%)
$6.77B(+7.1%)
Mar 2012
-
$1.35B(-50.2%)
$6.32B(-5.5%)
Dec 2011
$6.52B
$2.71B(+59.2%)
$6.69B(-7.1%)
Sep 2011
-
$1.70B(+204.7%)
$7.19B(-6.8%)
DateAnnualQuarterlyTTM
Jun 2011
-
$558.46M(-67.5%)
$7.72B(-22.4%)
Mar 2011
-
$1.72B(-46.6%)
$9.95B(+1.3%)
Dec 2010
$8.50B(-16.3%)
$3.22B(+44.6%)
$9.82B(-2.5%)
Sep 2010
-
$2.22B(-20.3%)
$10.07B(+2.6%)
Jun 2010
-
$2.79B(+75.5%)
$9.82B(-0.6%)
Mar 2010
-
$1.59B(-54.2%)
$9.87B(-4.5%)
Dec 2009
$10.15B(+115.9%)
$3.47B(+75.9%)
$10.34B(+11.8%)
Sep 2009
-
$1.97B(-30.7%)
$9.25B(+6.8%)
Jun 2009
-
$2.84B(+38.2%)
$8.66B(+15.8%)
Mar 2009
-
$2.06B(-13.5%)
$7.48B(-1.8%)
Dec 2008
$4.70B(-19.3%)
$2.38B(+72.1%)
$7.62B(-2.7%)
Sep 2008
-
$1.38B(-16.8%)
$7.83B(+3.3%)
Jun 2008
-
$1.66B(-24.2%)
$7.58B(+12.2%)
Mar 2008
-
$2.19B(-15.3%)
$6.76B(+1.8%)
Dec 2007
$5.83B(-8.2%)
$2.59B(+128.2%)
$6.64B(+9.3%)
Sep 2007
-
$1.14B(+35.1%)
$6.08B(-13.1%)
Jun 2007
-
$840.00M(-59.6%)
$6.99B(-11.9%)
Mar 2007
-
$2.08B(+2.7%)
$7.94B(+9.5%)
Dec 2006
$6.35B(+7.1%)
$2.02B(-1.2%)
$7.25B(+3.5%)
Sep 2006
-
$2.05B(+14.6%)
$7.00B(+6.8%)
Jun 2006
-
$1.79B(+28.5%)
$6.56B(+5.6%)
Mar 2006
-
$1.39B(-21.7%)
$6.21B(+1.1%)
Dec 2005
$5.93B(+58.0%)
$1.78B(+10.8%)
$6.14B(-0.4%)
Sep 2005
-
$1.60B(+11.4%)
$6.16B(+14.1%)
Jun 2005
-
$1.44B(+8.8%)
$5.40B(+22.5%)
Mar 2005
-
$1.32B(-26.6%)
$4.41B(+13.7%)
Dec 2004
$3.75B(+80.0%)
$1.80B(+114.6%)
$3.88B(+17.0%)
Sep 2004
-
$839.42M(+88.1%)
$3.31B(+0.9%)
Jun 2004
-
$446.34M(-43.6%)
$3.29B(-0.1%)
Mar 2004
-
$791.57M(-36.0%)
$3.29B(-4.0%)
Dec 2003
$2.09B(-40.3%)
$1.24B(+52.6%)
$3.43B(-5.1%)
Sep 2003
-
$810.77M(+80.2%)
$3.61B(+1.7%)
Jun 2003
-
$450.00M(-51.5%)
$3.55B(-9.6%)
Mar 2003
-
$928.67M(-34.7%)
$3.93B(-18.9%)
Dec 2002
$3.49B(+100.6%)
$1.42B(+89.9%)
$4.84B(+19.3%)
Sep 2002
-
$748.83M(-9.6%)
$4.06B(-6.8%)
Jun 2002
-
$828.05M(-55.1%)
$4.36B(+16.5%)
Mar 2002
-
$1.84B(+188.2%)
$3.74B(+19.7%)
Dec 2001
$1.74B(+98.9%)
$640.08M(-38.6%)
$3.13B(+8069.4%)
Sep 2001
-
$1.04B(+391.3%)
$38.26M(-97.7%)
Jun 2001
-
$212.27M(-82.8%)
$1.64B(-15.8%)
Mar 2001
-
$1.23B(-150.3%)
$1.95B(+122.9%)
Dec 2000
$875.25M(+37.8%)
-$2.45B(-192.5%)
$875.25M(-73.7%)
Sep 2000
-
$2.65B(+407.7%)
$3.32B(+391.5%)
Jun 2000
-
$521.29M(+236.8%)
$676.09M(+336.8%)
Mar 2000
-
$154.80M
$154.80M
Dec 1999
$635.00M(-68.7%)
-
-
Dec 1998
$2.03B(<-9900.0%)
-
-
Dec 1997
-$8.27M(-105.5%)
-
-
Dec 1996
$148.99M(-3.6%)
-
-
Dec 1995
$154.52M(+16.3%)
-
-
Dec 1994
$132.89M(-45.2%)
-
-
Dec 1993
$242.59M(-221.2%)
-
-
Dec 1992
-$200.20M(-267.2%)
-
-
Dec 1991
$119.76M(-55.0%)
-
-
Dec 1990
$266.19M
-
-

FAQ

  • What is AstraZeneca PLC annual free cash flow?
  • What is the all time high annual FCF for AstraZeneca PLC?
  • What is AstraZeneca PLC annual FCF year-on-year change?
  • What is AstraZeneca PLC quarterly free cash flow?
  • What is the all time high quarterly FCF for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly FCF year-on-year change?
  • What is AstraZeneca PLC TTM free cash flow?
  • What is the all time high TTM FCF for AstraZeneca PLC?
  • What is AstraZeneca PLC TTM FCF year-on-year change?

What is AstraZeneca PLC annual free cash flow?

The current annual FCF of AZN is $7.28B

What is the all time high annual FCF for AstraZeneca PLC?

AstraZeneca PLC all-time high annual free cash flow is $10.15B

What is AstraZeneca PLC annual FCF year-on-year change?

Over the past year, AZN annual free cash flow has changed by +$708.00M (+10.78%)

What is AstraZeneca PLC quarterly free cash flow?

The current quarterly FCF of AZN is $1.56B

What is the all time high quarterly FCF for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly free cash flow is $3.47B

What is AstraZeneca PLC quarterly FCF year-on-year change?

Over the past year, AZN quarterly free cash flow has changed by -$968.74M (-38.29%)

What is AstraZeneca PLC TTM free cash flow?

The current TTM FCF of AZN is $8.49B

What is the all time high TTM FCF for AstraZeneca PLC?

AstraZeneca PLC all-time high TTM free cash flow is $10.34B

What is AstraZeneca PLC TTM FCF year-on-year change?

Over the past year, AZN TTM free cash flow has changed by +$1.16B (+15.84%)
On this page